Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q4 2019 Earnings

12NovConfirmed

Q1 2019

Q2 2019

Q3 2019

Q4 2019

-0.17

-0.11

-0.05

0.01

Details

Expected EPS

-0.12

Actual EPS

-0.17

Surprise EPS

-0.05

Surprise Percent

+41.67%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.17 per share for Q4 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.